Cite
Papp KV, Samaroo A, Chou HC, et al. Unsupervised mobile cognitive testing for use in preclinical Alzheimer's disease. Alzheimers Dement (Amst). 2021;13(1):e12243doi: 10.1002/dad2.12243.
Papp, K. V., Samaroo, A., Chou, H. C., Buckley, R., Schneider, O. R., Hsieh, S., Soberanes, D., Quiroz, Y., Properzi, M., Schultz, A., García-Magariño, I., Marshall, G. A., Burke, J. G., Kumar, R., Snyder, N., Johnson, K., Rentz, D. M., Sperling, R. A., & Amariglio, R. E. (2021). Unsupervised mobile cognitive testing for use in preclinical Alzheimer's disease. Alzheimer's & dementia (Amsterdam, Netherlands), 13(1), e12243. https://doi.org/10.1002/dad2.12243
Papp, Kathryn V, et al. "Unsupervised mobile cognitive testing for use in preclinical Alzheimer's disease." Alzheimer's & dementia (Amsterdam, Netherlands) vol. 13,1 (2021): e12243. doi: https://doi.org/10.1002/dad2.12243
Papp KV, Samaroo A, Chou HC, Buckley R, Schneider OR, Hsieh S, Soberanes D, Quiroz Y, Properzi M, Schultz A, García-Magariño I, Marshall GA, Burke JG, Kumar R, Snyder N, Johnson K, Rentz DM, Sperling RA, Amariglio RE. Unsupervised mobile cognitive testing for use in preclinical Alzheimer's disease. Alzheimers Dement (Amst). 2021 Sep 30;13(1):e12243. doi: 10.1002/dad2.12243. eCollection 2021. PMID: 34621977; PMCID: PMC8481881.
Copy
Download .nbib